Price (delayed)
$9.98
Market cap
$103.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$19.41
Enterprise value
$21.83M
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases. The company is advancing its clinical-stage pipeline of
There are no recent dividends present for AVTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.